Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Androgens increase cervical cancer risk and affect its development.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

New treatments for hair loss are being developed using molecular biology.

Purple corn extract may help reduce prostate enlargement and inflammation.

High TNF-α levels may increase hair loss risk after PRP therapy.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Clascoterone cream is a safer, effective acne treatment with fewer side effects.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Finasteride helps reduce heart issues and improves heart function.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The method accurately measures seven androgens in plasma and shows different hormone levels in females with acne and obesity.

Moxibustion may help improve ovarian function by changing androgen levels.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.